Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Luc Galzi

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Traffic (Copenhagen, Denmark)|December 20, 2007
Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitizationMoussa Ouedraogo, Sandra Lecat, Moulay Driss Rochdi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2009
Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonistXavier Iturrioz, Rodrigo Alvear-Perez, Nadia De Mota, et al.
Journal of Medicinal Chemistry|August 15, 2018
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway HypereosinophiliaPierre Regenass, Dayana Abboud, François Daubeuf, et al.
The Journal of Biological Chemistry|June 17, 2008
Small neutralizing molecules to inhibit actions of the chemokine CXCL12Muriel Hachet-Haas, Karl Balabanian, François Rohmer, et al.
Cell Reports|April 30, 2015
Discovery and characterization of an endogenous CXCR4 antagonistOnofrio Zirafi, Kyeong-Ae Kim, Ludger Ständker, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Traffic (Copenhagen, Denmark)|December 20, 2007
Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitizationMoussa Ouedraogo, Sandra Lecat, Moulay Driss Rochdi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 31, 2009
Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonistXavier Iturrioz, Rodrigo Alvear-Perez, Nadia De Mota, et al.
Journal of Medicinal Chemistry|August 15, 2018
Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway HypereosinophiliaPierre Regenass, Dayana Abboud, François Daubeuf, et al.
The Journal of Biological Chemistry|June 17, 2008
Small neutralizing molecules to inhibit actions of the chemokine CXCL12Muriel Hachet-Haas, Karl Balabanian, François Rohmer, et al.
Cell Reports|April 30, 2015
Discovery and characterization of an endogenous CXCR4 antagonistOnofrio Zirafi, Kyeong-Ae Kim, Ludger Ständker, et al.
Pageof 5